Loxapine succinate in the treatment of newly admitted schizophrenic patients.
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D010054:Brief Psychiatric Rating Scale; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000627:therapeutic use*; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008152:Loxapine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts; D011674:Pulse / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D003989:Dibenzoxazepines; D008152:Loxapine